

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.76152434 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.75861650 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.34150450 |
| 4 | vocalization behavior (GO:0071625) | 5.33523439 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.31661128 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.04860098 |
| 7 | glutamate secretion (GO:0014047) | 5.02682968 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95146806 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.86356529 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.80480215 |
| 11 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.77470579 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.66858116 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.54279507 |
| 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.53035106 |
| 15 | exploration behavior (GO:0035640) | 4.42961854 |
| 16 | neurotransmitter secretion (GO:0007269) | 4.35087646 |
| 17 | protein localization to synapse (GO:0035418) | 4.31032795 |
| 18 | regulation of synaptic vesicle transport (GO:1902803) | 4.30759601 |
| 19 | neuronal action potential propagation (GO:0019227) | 4.27393839 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.22869255 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.22819604 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.21754690 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 4.18574994 |
| 24 | gamma-aminobutyric acid transport (GO:0015812) | 4.07618244 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.03702928 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.02834128 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 4.02293236 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 3.84841726 |
| 29 | long-term memory (GO:0007616) | 3.81322859 |
| 30 | L-amino acid import (GO:0043092) | 3.77252779 |
| 31 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.70693738 |
| 32 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.63213899 |
| 33 | cellular potassium ion homeostasis (GO:0030007) | 3.58463510 |
| 34 | positive regulation of membrane potential (GO:0045838) | 3.57748680 |
| 35 | proline transport (GO:0015824) | 3.57456898 |
| 36 | long-term synaptic potentiation (GO:0060291) | 3.54576830 |
| 37 | regulation of synaptic plasticity (GO:0048167) | 3.52306108 |
| 38 | neurotransmitter transport (GO:0006836) | 3.50834319 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.50306987 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.43118604 |
| 41 | dendritic spine morphogenesis (GO:0060997) | 3.42234897 |
| 42 | layer formation in cerebral cortex (GO:0021819) | 3.40307255 |
| 43 | activation of protein kinase A activity (GO:0034199) | 3.40240123 |
| 44 | cerebellar granule cell differentiation (GO:0021707) | 3.39843538 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.34063553 |
| 46 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.32768572 |
| 47 | regulation of neurotransmitter levels (GO:0001505) | 3.31540712 |
| 48 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.30241401 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.29989245 |
| 50 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.29551129 |
| 51 | response to histamine (GO:0034776) | 3.24232167 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.21022842 |
| 53 | serotonin metabolic process (GO:0042428) | 3.17658373 |
| 54 | synaptic vesicle endocytosis (GO:0048488) | 3.17425541 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.16126791 |
| 56 | neuron recognition (GO:0008038) | 3.15168527 |
| 57 | neuronal ion channel clustering (GO:0045161) | 3.14809336 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.13500176 |
| 59 | sodium ion export (GO:0071436) | 3.12560357 |
| 60 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.12364704 |
| 61 | neuromuscular process controlling balance (GO:0050885) | 3.10666867 |
| 62 | presynaptic membrane assembly (GO:0097105) | 3.10431763 |
| 63 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.09262001 |
| 64 | behavioral response to cocaine (GO:0048148) | 3.08619087 |
| 65 | regulation of female receptivity (GO:0045924) | 3.05631646 |
| 66 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.05512080 |
| 67 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.03990373 |
| 68 | neuromuscular process controlling posture (GO:0050884) | 3.02899116 |
| 69 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.02785847 |
| 70 | behavioral fear response (GO:0001662) | 3.02098379 |
| 71 | behavioral defense response (GO:0002209) | 3.02098379 |
| 72 | vesicle transport along microtubule (GO:0047496) | 2.98813057 |
| 73 | positive regulation of neurotransmitter transport (GO:0051590) | 2.98331406 |
| 74 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.96674457 |
| 75 | membrane depolarization (GO:0051899) | 2.96146142 |
| 76 | positive regulation of synaptic transmission (GO:0050806) | 2.94574387 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 2.94428019 |
| 78 | axon ensheathment in central nervous system (GO:0032291) | 2.92956344 |
| 79 | central nervous system myelination (GO:0022010) | 2.92956344 |
| 80 | regulation of vesicle fusion (GO:0031338) | 2.92734502 |
| 81 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.92469032 |
| 82 | regulation of ARF protein signal transduction (GO:0032012) | 2.92174653 |
| 83 | prepulse inhibition (GO:0060134) | 2.91962738 |
| 84 | long term synaptic depression (GO:0060292) | 2.91254323 |
| 85 | postsynaptic membrane organization (GO:0001941) | 2.90044760 |
| 86 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.89888537 |
| 87 | learning (GO:0007612) | 2.89696614 |
| 88 | auditory behavior (GO:0031223) | 2.89421606 |
| 89 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.89230021 |
| 90 | presynaptic membrane organization (GO:0097090) | 2.88636027 |
| 91 | innervation (GO:0060384) | 2.88293135 |
| 92 | axonal fasciculation (GO:0007413) | 2.86918947 |
| 93 | membrane depolarization during action potential (GO:0086010) | 2.86827646 |
| 94 | regulation of synaptic transmission (GO:0050804) | 2.86672693 |
| 95 | fear response (GO:0042596) | 2.85232604 |
| 96 | response to auditory stimulus (GO:0010996) | 2.84614788 |
| 97 | synaptic transmission (GO:0007268) | 2.84541683 |
| 98 | membrane hyperpolarization (GO:0060081) | 2.84517171 |
| 99 | amino acid import (GO:0043090) | 2.84313380 |
| 100 | female mating behavior (GO:0060180) | 2.83865811 |
| 101 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.83080799 |
| 102 | regulation of dendritic spine development (GO:0060998) | 2.82992719 |
| 103 | glycine transport (GO:0015816) | 2.82913944 |
| 104 | relaxation of smooth muscle (GO:0044557) | 2.82425758 |
| 105 | social behavior (GO:0035176) | 2.81898653 |
| 106 | intraspecies interaction between organisms (GO:0051703) | 2.81898653 |
| 107 | detection of molecule of bacterial origin (GO:0032490) | 2.80275540 |
| 108 | primary amino compound metabolic process (GO:1901160) | 2.78032204 |
| 109 | dendrite morphogenesis (GO:0048813) | 2.77083978 |
| 110 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.76879220 |
| 111 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.76043064 |
| 112 | neuromuscular process (GO:0050905) | 2.75382937 |
| 113 | regulation of beta-amyloid formation (GO:1902003) | 2.75288195 |
| 114 | negative regulation of dendrite development (GO:2000171) | 2.75163060 |
| 115 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.72456381 |
| 116 | potassium ion import (GO:0010107) | 2.70976196 |
| 117 | cell differentiation in hindbrain (GO:0021533) | 2.63409188 |
| 118 | microglial cell activation (GO:0001774) | 2.63174786 |
| 119 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.60178909 |
| 120 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.56493919 |
| 121 | startle response (GO:0001964) | 2.48343950 |
| 122 | neurotransmitter uptake (GO:0001504) | 2.47187964 |
| 123 | regulation of exocytosis (GO:0017157) | 2.47176804 |
| 124 | relaxation of cardiac muscle (GO:0055119) | 2.44577525 |
| 125 | detection of calcium ion (GO:0005513) | 2.44227811 |
| 126 | cellular response to ethanol (GO:0071361) | 2.42889516 |
| 127 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.40888349 |
| 128 | macroautophagy (GO:0016236) | 2.40386018 |
| 129 | import into cell (GO:0098657) | 2.38411669 |
| 130 | cellular sodium ion homeostasis (GO:0006883) | 2.38352138 |
| 131 | cellular potassium ion transport (GO:0071804) | 2.36345276 |
| 132 | potassium ion transmembrane transport (GO:0071805) | 2.36345276 |
| 133 | cellular response to epinephrine stimulus (GO:0071872) | 2.35157281 |
| 134 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.34625613 |
| 135 | positive regulation of myoblast differentiation (GO:0045663) | 2.33604428 |
| 136 | positive regulation of Rap GTPase activity (GO:0032854) | 2.32545370 |
| 137 | adult walking behavior (GO:0007628) | 2.30471942 |
| 138 | establishment of protein localization to Golgi (GO:0072600) | 2.30170256 |
| 139 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.29892703 |
| 140 | regulation of Rap GTPase activity (GO:0032317) | 2.29461934 |
| 141 | macrophage activation involved in immune response (GO:0002281) | 2.28760958 |
| 142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.28486986 |
| 143 | negative regulation of neurotransmitter transport (GO:0051589) | 2.26644531 |
| 144 | potassium ion transport (GO:0006813) | 2.24863958 |
| 145 | macrophage activation (GO:0042116) | 2.24305552 |
| 146 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.23728077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.52115274 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.61614653 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98320843 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92897599 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77516370 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.60209166 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.51056482 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.50404382 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49961328 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49961328 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.41338213 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41307814 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.40641340 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.36741465 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.34702416 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30470344 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13727926 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.13469810 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07961835 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.03466405 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.99635037 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99397637 |
| 23 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.92722513 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.92280575 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92009708 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.86863798 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.81474072 |
| 28 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.80647202 |
| 29 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77763525 |
| 30 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.75420369 |
| 31 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.72631696 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.70774017 |
| 33 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69320744 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68970120 |
| 35 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59344403 |
| 36 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.57345846 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.53157384 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.48245672 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.47317573 |
| 40 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.41958191 |
| 41 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41200901 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40853386 |
| 43 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37236026 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36495024 |
| 45 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34935239 |
| 46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32553948 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31797116 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31422915 |
| 49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.30321599 |
| 50 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27726589 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26237185 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26213397 |
| 53 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.24739045 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24369682 |
| 55 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24335193 |
| 56 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23023654 |
| 57 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22760639 |
| 58 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21680911 |
| 59 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21680911 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20149212 |
| 61 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18930629 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18406171 |
| 63 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18352994 |
| 64 | AR_19668381_ChIP-Seq_PC3_Human | 1.18245623 |
| 65 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16655957 |
| 66 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16140342 |
| 67 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15002994 |
| 68 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.14415033 |
| 69 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14303887 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13977655 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.12730875 |
| 72 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12456957 |
| 73 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.11875050 |
| 74 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11777339 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11327528 |
| 76 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.11215748 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10200170 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10166535 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09370984 |
| 80 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.08408743 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.07396285 |
| 82 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07066384 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07053963 |
| 84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.06588377 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05668599 |
| 86 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05458024 |
| 87 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05105768 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.04924681 |
| 89 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04333361 |
| 90 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04259581 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.03882407 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.03053018 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.02814560 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01799545 |
| 95 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01147291 |
| 96 | TP53_16413492_ChIP-PET_HCT116_Human | 1.00304851 |
| 97 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99903915 |
| 98 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.99359005 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99265256 |
| 100 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98692392 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98349455 |
| 102 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98346098 |
| 103 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97655425 |
| 104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97461583 |
| 105 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97461583 |
| 106 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97403839 |
| 107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.97312111 |
| 108 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97025636 |
| 109 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96373134 |
| 110 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.96276626 |
| 111 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96066238 |
| 112 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.94951369 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94927735 |
| 114 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93896093 |
| 115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93350521 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91574549 |
| 117 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90909928 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88789640 |
| 119 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88778205 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87184343 |
| 121 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86996298 |
| 122 | JUN_21703547_ChIP-Seq_K562_Human | 0.86945885 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86368599 |
| 124 | FUS_26573619_Chip-Seq_HEK293_Human | 0.86296145 |
| 125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86119808 |
| 126 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86035724 |
| 127 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85292683 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84367032 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82783026 |
| 130 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.82069802 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.52377428 |
| 2 | MP0003880_abnormal_central_pattern | 4.71746892 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.13152638 |
| 4 | MP0004270_analgesia | 3.63787320 |
| 5 | MP0009745_abnormal_behavioral_response | 3.50319216 |
| 6 | MP0002822_catalepsy | 3.41589943 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.34091703 |
| 8 | MP0002064_seizures | 3.21153880 |
| 9 | MP0009046_muscle_twitch | 3.01740015 |
| 10 | MP0001968_abnormal_touch/_nociception | 3.01592545 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.80323641 |
| 12 | MP0002272_abnormal_nervous_system | 2.58263997 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.48168606 |
| 14 | MP0001486_abnormal_startle_reflex | 2.48047178 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.40319310 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.37285382 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.32662125 |
| 18 | MP0002736_abnormal_nociception_after | 2.31907745 |
| 19 | MP0003724_increased_susceptibility_to | 2.21472903 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.19342389 |
| 21 | MP0001440_abnormal_grooming_behavior | 2.07567027 |
| 22 | MP0003329_amyloid_beta_deposits | 1.99075656 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.90670671 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.89786693 |
| 25 | MP0001970_abnormal_pain_threshold | 1.84678811 |
| 26 | MP0002909_abnormal_adrenal_gland | 1.82879519 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.79492024 |
| 28 | MP0003045_fibrosis | 1.77264387 |
| 29 | MP0008569_lethality_at_weaning | 1.71625132 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.68756042 |
| 31 | MP0004924_abnormal_behavior | 1.68756042 |
| 32 | MP0003879_abnormal_hair_cell | 1.65990580 |
| 33 | MP0004858_abnormal_nervous_system | 1.62626066 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.62287557 |
| 35 | MP0004811_abnormal_neuron_physiology | 1.58205728 |
| 36 | MP0002184_abnormal_innervation | 1.51308393 |
| 37 | MP0001984_abnormal_olfaction | 1.48866241 |
| 38 | MP0003633_abnormal_nervous_system | 1.48429240 |
| 39 | MP0006276_abnormal_autonomic_nervous | 1.42205634 |
| 40 | MP0008877_abnormal_DNA_methylation | 1.40166755 |
| 41 | MP0000778_abnormal_nervous_system | 1.36688452 |
| 42 | MP0004885_abnormal_endolymph | 1.36231519 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.34930904 |
| 44 | MP0000955_abnormal_spinal_cord | 1.30033607 |
| 45 | MP0001529_abnormal_vocalization | 1.22459149 |
| 46 | MP0003303_peritoneal_inflammation | 1.21913576 |
| 47 | MP0008872_abnormal_physiological_respon | 1.21893796 |
| 48 | MP0003631_nervous_system_phenotype | 1.21307895 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.19576454 |
| 50 | MP0005085_abnormal_gallbladder_physiolo | 1.18365433 |
| 51 | MP0003787_abnormal_imprinting | 1.17887065 |
| 52 | MP0005360_urolithiasis | 1.17472416 |
| 53 | MP0000604_amyloidosis | 1.16123231 |
| 54 | MP0002139_abnormal_hepatobiliary_system | 1.14792072 |
| 55 | MP0008874_decreased_physiological_sensi | 1.14742650 |
| 56 | MP0005535_abnormal_body_temperature | 1.13658045 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.13287272 |
| 58 | MP0002837_dystrophic_cardiac_calcinosis | 1.11239476 |
| 59 | MP0001502_abnormal_circadian_rhythm | 1.09600054 |
| 60 | MP0001905_abnormal_dopamine_level | 1.08139727 |
| 61 | MP0004142_abnormal_muscle_tone | 1.07234445 |
| 62 | MP0003075_altered_response_to | 1.06401375 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.06325473 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06235182 |
| 65 | MP0005645_abnormal_hypothalamus_physiol | 1.05933583 |
| 66 | MP0003690_abnormal_glial_cell | 1.05502656 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.03483390 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.03273811 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.01122808 |
| 70 | MP0004043_abnormal_pH_regulation | 1.00692273 |
| 71 | MP0002069_abnormal_eating/drinking_beha | 1.00342883 |
| 72 | MP0001177_atelectasis | 1.00246436 |
| 73 | MP0005310_abnormal_salivary_gland | 0.99457673 |
| 74 | MP0000013_abnormal_adipose_tissue | 0.98899446 |
| 75 | MP0008004_abnormal_stomach_pH | 0.96894004 |
| 76 | MP0005174_abnormal_tail_pigmentation | 0.96021658 |
| 77 | MP0002229_neurodegeneration | 0.95010450 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.94624172 |
| 79 | MP0005464_abnormal_platelet_physiology | 0.89805684 |
| 80 | MP0002152_abnormal_brain_morphology | 0.88992124 |
| 81 | MP0000569_abnormal_digit_pigmentation | 0.84981653 |
| 82 | MP0004510_myositis | 0.84806096 |
| 83 | MP0001188_hyperpigmentation | 0.83539411 |
| 84 | MP0005365_abnormal_bile_salt | 0.82062107 |
| 85 | MP0005551_abnormal_eye_electrophysiolog | 0.81942020 |
| 86 | MP0003632_abnormal_nervous_system | 0.80929683 |
| 87 | MP0002090_abnormal_vision | 0.80181936 |
| 88 | MP0004085_abnormal_heartbeat | 0.80022500 |
| 89 | MP0010329_abnormal_lipoprotein_level | 0.79581381 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.79508974 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.78039825 |
| 92 | MP0004147_increased_porphyrin_level | 0.77548200 |
| 93 | MP0008961_abnormal_basal_metabolism | 0.76734419 |
| 94 | MP0000920_abnormal_myelination | 0.75749303 |
| 95 | MP0003122_maternal_imprinting | 0.73442424 |
| 96 | MP0003866_abnormal_defecation | 0.73428046 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.70860332 |
| 98 | MP0001963_abnormal_hearing_physiology | 0.69600807 |
| 99 | MP0001664_abnormal_digestion | 0.69587602 |
| 100 | MP0003634_abnormal_glial_cell | 0.68288177 |
| 101 | MP0000751_myopathy | 0.67723342 |
| 102 | MP0004742_abnormal_vestibular_system | 0.67548365 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.66910127 |
| 104 | MP0002168_other_aberrant_phenotype | 0.66751492 |
| 105 | MP0004381_abnormal_hair_follicle | 0.64848746 |
| 106 | MP0005166_decreased_susceptibility_to | 0.64499264 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.64340450 |
| 108 | MP0002419_abnormal_innate_immunity | 0.63520323 |
| 109 | MP0004484_altered_response_of | 0.61808677 |
| 110 | MP0004130_abnormal_muscle_cell | 0.61205016 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.61100725 |
| 112 | MP0003195_calcinosis | 0.61022395 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.60886559 |
| 114 | MP0003252_abnormal_bile_duct | 0.60512973 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.60412566 |
| 116 | MP0003191_abnormal_cellular_cholesterol | 0.59637632 |
| 117 | MP0003283_abnormal_digestive_organ | 0.59078718 |
| 118 | MP0004215_abnormal_myocardial_fiber | 0.57871528 |
| 119 | MP0004145_abnormal_muscle_electrophysio | 0.57286019 |
| 120 | MP0005448_abnormal_energy_balance | 0.54692283 |
| 121 | MP0003183_abnormal_peptide_metabolism | 0.52783420 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52733176 |
| 123 | MP0005332_abnormal_amino_acid | 0.51463142 |
| 124 | MP0002078_abnormal_glucose_homeostasis | 0.51141316 |
| 125 | MP0002118_abnormal_lipid_homeostasis | 0.50504124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.33829388 |
| 2 | Myokymia (HP:0002411) | 6.79543055 |
| 3 | Focal seizures (HP:0007359) | 5.84921145 |
| 4 | Visual hallucinations (HP:0002367) | 4.98550428 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.93180834 |
| 6 | Atonic seizures (HP:0010819) | 4.79152994 |
| 7 | Febrile seizures (HP:0002373) | 4.57082409 |
| 8 | Absence seizures (HP:0002121) | 4.47087952 |
| 9 | Hyperventilation (HP:0002883) | 4.33879270 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.13396608 |
| 11 | Dialeptic seizures (HP:0011146) | 4.07773056 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.03543753 |
| 13 | Action tremor (HP:0002345) | 3.85698751 |
| 14 | Poor eye contact (HP:0000817) | 3.53265102 |
| 15 | Broad-based gait (HP:0002136) | 3.48233371 |
| 16 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.43286923 |
| 17 | Abnormal social behavior (HP:0012433) | 3.40823511 |
| 18 | Impaired social interactions (HP:0000735) | 3.40823511 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.33693626 |
| 20 | Supranuclear gaze palsy (HP:0000605) | 3.30394918 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.24916134 |
| 22 | Depression (HP:0000716) | 3.14947049 |
| 23 | Retrobulbar optic neuritis (HP:0100654) | 3.12383792 |
| 24 | Optic neuritis (HP:0100653) | 3.12383792 |
| 25 | Dysmetria (HP:0001310) | 3.12353242 |
| 26 | Anxiety (HP:0000739) | 3.10464672 |
| 27 | Postural instability (HP:0002172) | 3.10287828 |
| 28 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.02870522 |
| 29 | Orchitis (HP:0100796) | 2.97521162 |
| 30 | Status epilepticus (HP:0002133) | 2.97080235 |
| 31 | Ankle clonus (HP:0011448) | 2.94721552 |
| 32 | Truncal ataxia (HP:0002078) | 2.90983887 |
| 33 | Abnormal eating behavior (HP:0100738) | 2.88121729 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.84324810 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.83150042 |
| 36 | Torticollis (HP:0000473) | 2.80580227 |
| 37 | Excessive salivation (HP:0003781) | 2.80176262 |
| 38 | Drooling (HP:0002307) | 2.80176262 |
| 39 | Amblyopia (HP:0000646) | 2.80037828 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.78621989 |
| 41 | Papilledema (HP:0001085) | 2.77320338 |
| 42 | Scanning speech (HP:0002168) | 2.75452190 |
| 43 | Focal dystonia (HP:0004373) | 2.72797996 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.72752100 |
| 45 | Intention tremor (HP:0002080) | 2.67567397 |
| 46 | Progressive inability to walk (HP:0002505) | 2.63085649 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.62237520 |
| 48 | Myositis (HP:0100614) | 2.61971730 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.59627591 |
| 50 | Bradykinesia (HP:0002067) | 2.58208763 |
| 51 | Dysmetric saccades (HP:0000641) | 2.54835299 |
| 52 | Mutism (HP:0002300) | 2.53754510 |
| 53 | Urinary urgency (HP:0000012) | 2.52967171 |
| 54 | Impaired vibratory sensation (HP:0002495) | 2.51322321 |
| 55 | Spastic gait (HP:0002064) | 2.50271111 |
| 56 | Hypsarrhythmia (HP:0002521) | 2.50080456 |
| 57 | Insidious onset (HP:0003587) | 2.45360687 |
| 58 | Termporal pattern (HP:0011008) | 2.45360687 |
| 59 | Craniofacial dystonia (HP:0012179) | 2.44407298 |
| 60 | Generalized myoclonic seizures (HP:0002123) | 2.38619627 |
| 61 | Obstructive sleep apnea (HP:0002870) | 2.37234541 |
| 62 | Blue irides (HP:0000635) | 2.34353980 |
| 63 | Genetic anticipation (HP:0003743) | 2.32996981 |
| 64 | Absent speech (HP:0001344) | 2.31916579 |
| 65 | Stereotypic behavior (HP:0000733) | 2.31382764 |
| 66 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.31193394 |
| 67 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.31193394 |
| 68 | Pheochromocytoma (HP:0002666) | 2.28799062 |
| 69 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26409387 |
| 70 | Hemiplegia (HP:0002301) | 2.24856479 |
| 71 | Inability to walk (HP:0002540) | 2.24735900 |
| 72 | Abnormality of binocular vision (HP:0011514) | 2.24697687 |
| 73 | Diplopia (HP:0000651) | 2.24697687 |
| 74 | Hemiparesis (HP:0001269) | 2.21425120 |
| 75 | Resting tremor (HP:0002322) | 2.19563696 |
| 76 | Abnormality of the corticospinal tract (HP:0002492) | 2.18513003 |
| 77 | Stomatitis (HP:0010280) | 2.15644230 |
| 78 | Keratoconjunctivitis (HP:0001096) | 2.14933073 |
| 79 | Decreased circulating renin level (HP:0003351) | 2.12252986 |
| 80 | Syncope (HP:0001279) | 2.12146605 |
| 81 | Hypokalemic alkalosis (HP:0001949) | 2.08373414 |
| 82 | Prolonged QT interval (HP:0001657) | 2.05507670 |
| 83 | Keratoconjunctivitis sicca (HP:0001097) | 2.05311768 |
| 84 | Widely spaced teeth (HP:0000687) | 2.05075459 |
| 85 | Gait ataxia (HP:0002066) | 2.03664380 |
| 86 | Hyperaldosteronism (HP:0000859) | 2.02847303 |
| 87 | Agitation (HP:0000713) | 2.02555300 |
| 88 | Prolonged bleeding time (HP:0003010) | 2.00526138 |
| 89 | Psychosis (HP:0000709) | 2.00241919 |
| 90 | Neuronal loss in central nervous system (HP:0002529) | 1.99967161 |
| 91 | Lower limb muscle weakness (HP:0007340) | 1.99930992 |
| 92 | Ventricular fibrillation (HP:0001663) | 1.97962050 |
| 93 | Polyphagia (HP:0002591) | 1.97500368 |
| 94 | Neuroendocrine neoplasm (HP:0100634) | 1.96929083 |
| 95 | Clumsiness (HP:0002312) | 1.96226302 |
| 96 | Abnormal EKG (HP:0003115) | 1.94308710 |
| 97 | Fetal akinesia sequence (HP:0001989) | 1.93395441 |
| 98 | Generalized hypopigmentation of hair (HP:0011358) | 1.92542860 |
| 99 | Protruding tongue (HP:0010808) | 1.92073451 |
| 100 | Metabolic alkalosis (HP:0200114) | 1.92063429 |
| 101 | Rigidity (HP:0002063) | 1.91271480 |
| 102 | Megalencephaly (HP:0001355) | 1.91124739 |
| 103 | Vertigo (HP:0002321) | 1.91118265 |
| 104 | Pulmonary embolism (HP:0002204) | 1.90969286 |
| 105 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.90564942 |
| 106 | Gingival bleeding (HP:0000225) | 1.87478605 |
| 107 | Spontaneous hematomas (HP:0007420) | 1.87401011 |
| 108 | Hypochromic microcytic anemia (HP:0004840) | 1.87288712 |
| 109 | Annular pancreas (HP:0001734) | 1.86702321 |
| 110 | Abnormality of saccadic eye movements (HP:0000570) | 1.85445951 |
| 111 | Ocular albinism (HP:0001107) | 1.84770956 |
| 112 | Clonus (HP:0002169) | 1.84071754 |
| 113 | Abnormality of salivation (HP:0100755) | 1.83936330 |
| 114 | Incomplete penetrance (HP:0003829) | 1.83131631 |
| 115 | Delusions (HP:0000746) | 1.81613095 |
| 116 | Eczematoid dermatitis (HP:0000976) | 1.80271133 |
| 117 | Fair hair (HP:0002286) | 1.80129843 |
| 118 | Spastic tetraparesis (HP:0001285) | 1.79750796 |
| 119 | Limb dystonia (HP:0002451) | 1.78401713 |
| 120 | Memory impairment (HP:0002354) | 1.77845890 |
| 121 | Bundle branch block (HP:0011710) | 1.77006089 |
| 122 | Abnormality of renin-angiotensin system (HP:0000847) | 1.76322023 |
| 123 | Recurrent bacterial skin infections (HP:0005406) | 1.74649070 |
| 124 | Tetraplegia (HP:0002445) | 1.74483773 |
| 125 | Abnormality of the periventricular white matter (HP:0002518) | 1.71322238 |
| 126 | Postural tremor (HP:0002174) | 1.71199688 |
| 127 | Episodic fever (HP:0001954) | 1.70543466 |
| 128 | Global brain atrophy (HP:0002283) | 1.69817691 |
| 129 | Lower limb asymmetry (HP:0100559) | 1.69683146 |
| 130 | Papillary thyroid carcinoma (HP:0002895) | 1.67843907 |
| 131 | Testicular neoplasm (HP:0010788) | 1.66667237 |
| 132 | Amyotrophic lateral sclerosis (HP:0007354) | 1.66483348 |
| 133 | Iris hypopigmentation (HP:0007730) | 1.66373966 |
| 134 | Abnormal gallbladder physiology (HP:0012438) | 1.63713862 |
| 135 | Cholecystitis (HP:0001082) | 1.63713862 |
| 136 | Increased circulating renin level (HP:0000848) | 1.62341086 |
| 137 | Inappropriate behavior (HP:0000719) | 1.59594773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.71058983 |
| 2 | NTRK3 | 4.52900450 |
| 3 | MAP3K9 | 3.59885993 |
| 4 | MAP3K4 | 3.19493307 |
| 5 | DAPK2 | 2.80719525 |
| 6 | MAP2K7 | 2.71230737 |
| 7 | MINK1 | 2.50591455 |
| 8 | RIPK4 | 2.40973189 |
| 9 | MAP2K4 | 2.35191782 |
| 10 | MARK1 | 2.34821066 |
| 11 | MAP3K12 | 2.20274912 |
| 12 | KSR2 | 2.17877178 |
| 13 | CASK | 2.07921921 |
| 14 | NTRK1 | 1.95290145 |
| 15 | PRKD3 | 1.94779235 |
| 16 | PAK6 | 1.92362742 |
| 17 | CAMKK1 | 1.91250624 |
| 18 | DAPK1 | 1.82105505 |
| 19 | NTRK2 | 1.75174148 |
| 20 | KSR1 | 1.52053926 |
| 21 | BLK | 1.50849490 |
| 22 | CDK5 | 1.49731088 |
| 23 | GRK5 | 1.43546551 |
| 24 | MAP3K2 | 1.41177784 |
| 25 | PLK2 | 1.39916050 |
| 26 | TAOK3 | 1.34970143 |
| 27 | STK38 | 1.33091759 |
| 28 | ARAF | 1.32978347 |
| 29 | ACVR1B | 1.32020501 |
| 30 | MAP3K13 | 1.30624702 |
| 31 | CDK19 | 1.29641115 |
| 32 | PRKCG | 1.27167503 |
| 33 | CAMKK2 | 1.26089733 |
| 34 | TNIK | 1.23341415 |
| 35 | FES | 1.21469162 |
| 36 | PRPF4B | 1.19182929 |
| 37 | PNCK | 1.14211049 |
| 38 | SGK223 | 1.12305533 |
| 39 | SGK494 | 1.12305533 |
| 40 | SIK2 | 1.11941504 |
| 41 | OXSR1 | 1.07989710 |
| 42 | SGK2 | 1.03591786 |
| 43 | CAMK2A | 1.03120211 |
| 44 | AKT3 | 1.02803494 |
| 45 | STK39 | 1.00854229 |
| 46 | BMPR2 | 0.95503747 |
| 47 | MAPK13 | 0.95178674 |
| 48 | IRAK1 | 0.94065575 |
| 49 | CAMK2B | 0.93241082 |
| 50 | IRAK2 | 0.92196299 |
| 51 | SGK3 | 0.91674318 |
| 52 | CAMK1 | 0.90776572 |
| 53 | PINK1 | 0.89117053 |
| 54 | PTK2B | 0.88988526 |
| 55 | RET | 0.87040688 |
| 56 | PRKCH | 0.86274887 |
| 57 | JAK2 | 0.86061599 |
| 58 | JAK1 | 0.85503176 |
| 59 | IRAK4 | 0.84484376 |
| 60 | UHMK1 | 0.83937863 |
| 61 | TYRO3 | 0.83736313 |
| 62 | MAPK12 | 0.81061710 |
| 63 | SYK | 0.80865270 |
| 64 | PDK1 | 0.80084943 |
| 65 | STK11 | 0.79383109 |
| 66 | RAF1 | 0.75826325 |
| 67 | PDPK1 | 0.75368127 |
| 68 | SGK1 | 0.74708665 |
| 69 | CDK18 | 0.73998626 |
| 70 | MAP3K1 | 0.72969476 |
| 71 | BMPR1B | 0.71543556 |
| 72 | CDK15 | 0.71450578 |
| 73 | CDK14 | 0.70179712 |
| 74 | LATS2 | 0.68454372 |
| 75 | INSRR | 0.68445562 |
| 76 | TXK | 0.66667661 |
| 77 | TAOK1 | 0.65828722 |
| 78 | FGFR3 | 0.64986450 |
| 79 | ADRBK2 | 0.64493269 |
| 80 | PAK3 | 0.64271421 |
| 81 | GRK6 | 0.60516831 |
| 82 | EPHA3 | 0.59823527 |
| 83 | HIPK2 | 0.59753908 |
| 84 | ERBB2 | 0.59434098 |
| 85 | CDK11A | 0.59199613 |
| 86 | MAP3K7 | 0.58804874 |
| 87 | PRKCE | 0.56281216 |
| 88 | CSNK1G2 | 0.56000500 |
| 89 | HCK | 0.55647597 |
| 90 | PRKCZ | 0.55627032 |
| 91 | PHKG1 | 0.54559384 |
| 92 | PHKG2 | 0.54559384 |
| 93 | FER | 0.54405419 |
| 94 | CAMK2G | 0.54173316 |
| 95 | TEC | 0.53769437 |
| 96 | FRK | 0.53421270 |
| 97 | TNK2 | 0.53320569 |
| 98 | DYRK1A | 0.52862732 |
| 99 | WNK3 | 0.52175913 |
| 100 | LMTK2 | 0.52013516 |
| 101 | YES1 | 0.51806644 |
| 102 | CAMK2D | 0.51181476 |
| 103 | PRKAA2 | 0.50455686 |
| 104 | RPS6KA3 | 0.49896825 |
| 105 | MAP2K1 | 0.49752920 |
| 106 | ADRBK1 | 0.49021392 |
| 107 | CCNB1 | 0.48907624 |
| 108 | MAP3K6 | 0.48069011 |
| 109 | NME1 | 0.47879411 |
| 110 | SCYL2 | 0.46404337 |
| 111 | MARK2 | 0.45929247 |
| 112 | MAP2K6 | 0.45226013 |
| 113 | FYN | 0.44779502 |
| 114 | CAMK1G | 0.44415777 |
| 115 | CAMK4 | 0.44130451 |
| 116 | ALK | 0.43798939 |
| 117 | PRKG1 | 0.43187519 |
| 118 | MAP4K2 | 0.41123531 |
| 119 | FGR | 0.39344812 |
| 120 | NEK6 | 0.39273444 |
| 121 | FGFR2 | 0.38057473 |
| 122 | WNK1 | 0.37926603 |
| 123 | MAPK10 | 0.37505638 |
| 124 | BRAF | 0.36005372 |
| 125 | DAPK3 | 0.35868039 |
| 126 | SIK3 | 0.35652020 |
| 127 | RIPK1 | 0.35058311 |
| 128 | PRKCB | 0.33814395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.55623891 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10315688 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61170109 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.56592037 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53944679 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.49532762 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.49264120 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.40789512 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34684282 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.33557128 |
| 11 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.25587003 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.10937492 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.08345548 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96830524 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.92167154 |
| 16 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.74848329 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.71214170 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67405805 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.65454238 |
| 20 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.62618309 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.62605455 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.60089871 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.60052486 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59613331 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44760024 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.43920378 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.43728829 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43151225 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.41253965 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39052845 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23907064 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.22992987 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20464531 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20151215 |
| 35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.17846779 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16622780 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12280700 |
| 38 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.11241555 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.10918702 |
| 40 | ABC transporters_Homo sapiens_hsa02010 | 1.10266068 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.07554753 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05589257 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03286699 |
| 44 | Platelet activation_Homo sapiens_hsa04611 | 1.00670503 |
| 45 | Glioma_Homo sapiens_hsa05214 | 0.96410245 |
| 46 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.96404427 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95300369 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94411568 |
| 49 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93104199 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89351961 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88991123 |
| 52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88161406 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87461058 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.85585615 |
| 55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.83787060 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.83006599 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82144488 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81035628 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.80882137 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.80503612 |
| 61 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78729426 |
| 62 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73895418 |
| 63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71852404 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.68240261 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67840745 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67744056 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66323769 |
| 68 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65922566 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.65703354 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65115813 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.64325321 |
| 72 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61349885 |
| 73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61077187 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60745885 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.60503234 |
| 76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.58576660 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57655939 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57486353 |
| 79 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56187188 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56082889 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55984287 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.52558457 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52449685 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50653587 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.50520305 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.50126418 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47580582 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45367951 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45127618 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.45082357 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44666602 |
| 92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43998638 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43660606 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43609494 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43589181 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41122829 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40864056 |
| 98 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40564543 |
| 99 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38185300 |
| 100 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.37990307 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37644319 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36256735 |
| 103 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35789880 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.34454305 |
| 105 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.34131242 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.33335646 |
| 107 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32727334 |
| 108 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31733905 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31573919 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31219435 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30259190 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.29632084 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.29483013 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.28273952 |
| 115 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27907071 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27739860 |
| 117 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27612867 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27252948 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.25918011 |
| 120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.25841384 |
| 121 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.24506932 |
| 122 | Alzheimers disease_Homo sapiens_hsa05010 | 0.24315697 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.21935105 |
| 124 | Mineral absorption_Homo sapiens_hsa04978 | 0.21253247 |

